Table of Content

1. Executive Summary

2. Global Allergic Conjunctivitis Market and Patients Analysis
2.1 Allergic Conjunctivitis Market
2.2 Allergic Conjunctivitis Patient Numbers
2.3 Allergic Conjunctivitis Treated Patient Numbers

3. Share Analysis – Global Allergic Conjunctivitis
3.1 Country Market Share
3.2 Patients Population Share
3.3 Treated Patients Population Share
3.4 By Disease Type Share

4. India
4.1 Allergic Conjunctivitis Patient Numbers
4.2 Allergic Conjunctivitis Treated Patient Numbers
4.3 Allergic Conjunctivitis Market

5. China
5.1 Allergic Conjunctivitis Patient Numbers
5.2 Allergic Conjunctivitis Treated Patient Numbers
5.3 Allergic Conjunctivitis Market

6. Japan
6.1 Allergic Conjunctivitis Patient Numbers
6.2 Allergic Conjunctivitis Treated Patient Numbers
6.3 Allergic Conjunctivitis Market

7. United States
7.1 Allergic Conjunctivitis Patient Numbers
7.2 Allergic Conjunctivitis Treated Patient Numbers
7.3 Allergic Conjunctivitis Market

8. United Kingdom
8.1 Allergic Conjunctivitis Patient Numbers
8.2 Allergic Conjunctivitis Treated Patient Numbers
8.3 Allergic Conjunctivitis Market

9. France
9.1 Allergic Conjunctivitis Patient Numbers
9.2 Allergic Conjunctivitis Treated Patient Numbers
9.3 Allergic Conjunctivitis Market

10. Germany
10.1 Allergic Conjunctivitis Patient Numbers
10.2 Allergic Conjunctivitis Treated Patient Numbers
10.3 Allergic Conjunctivitis Market

11. Italy
11.1 Allergic Conjunctivitis Patient Numbers
11.2 Allergic Conjunctivitis Treated Patient Numbers
11.3 Allergic Conjunctivitis Market

12. Spain
12.1 Allergic Conjunctivitis Patient Numbers
12.2 Allergic Conjunctivitis Treated Patient Numbers
12.3 Allergic Conjunctivitis Market

13. Disease Type – Global Allergic Conjunctivitis Market
13.1 Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC)
13.2 Vernal Keratoconjunctivitis (VKC)
13.3 Atopic Keratoconjunctivitis (AKC)
13.4 Giant Papillary Conjunctivitis (GPC)

14. Global Allergic Conjunctivitis Drugs Profile/Pipe Line Drugs
14.1 Zerviate
14.2 OTX-DP (Dexamethasone Insert)
14.3 ADX-102
14.4 PRT2761
14.5 CVXL-0074
14.6 AK-002
14.7 Bertilimumab
14.8 Reproxalap
14.9 ST-266
14.10 SYL-116011

15. Growth Driver
15.1 Rapid Urbanization and Growth of Particulate Pollution
15.2 Increasing Ageing Population & Widespread Use of Medications for Various Eye Diseases

16. Challenges
16.1 Diagnostic Challenges
16.2 Undertreated by Patients

17. Santen Pharmaceutical
17.1 Company Overview
17.2 Initiatives
17.2.1 Point 1
17.2.2 Point 2
17.3 Financial Insight

18. Alcon Inc. (Novartis)
18.1 Company Overview
18.2 Initiatives
18.2.1 Point 1
18.2.2 Point 2
18.3 Financial Insight

19. Portola Pharmaceuticals Inc.
19.1 Company Overview
19.2 Initiatives
19.2.1 Point 1
19.2.2 Point 2
19.3 Financial Insight

20. Ocular Therapeutix Inc.
20.1 Company Overview
20.2 Initiatives
20.2.1 Point 1
20.2.2 Point 2
20.3 Financial Insight



List of Figures


List of Figures:
Figure 2 1: Global - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 2 2: Global – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 2 3: Global - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 2 4: Global – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 2 5: Global - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 2 6: Global – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 3 1: Global - Allergic Conjunctivitis Market Country Share (Percent), 2013 – 2018
Figure 3 2: Global – Forecast for Allergic Conjunctivitis Market Country Share (Percent), 2019 – 2025
Figure 3 3: Global - Allergic Conjunctivitis Treated Patients Population Country Share (Percent), 2013 – 2018
Figure 3 4: Global – Forecast for Allergic Conjunctivitis Treated Patients Population Country Share (Percent), 2019 – 2025
Figure 3 5: Global - Allergic Conjunctivitis Disease Type Market Share (Percent), 2013 – 2018
Figure 3 6: Global – Forecast for Allergic Conjunctivitis Disease Type Market Share (Percent), 2019 – 2025
Figure 4 1: India - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 4 2: India – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 4 3: India - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 4 4: India – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 4 5: India - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 4 6: India – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 5 1: China - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 5 2: China – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 5 3: China - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 5 4: China – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 5 5: China - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 5 6: China – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 6 1: Japan - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 6 2: Japan – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 6 3: Japan - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 6 4: Japan – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 6 5: Japan - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 6 6: Japan – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 7 1: United States - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 7 2: United States – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 7 3: United States - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 7 4: United States – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 7 5: United States - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 7 6: United States – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 8 1: United Kingdom - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 8 2: United Kingdom – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 8 3: United Kingdom - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 8 4: United Kingdom – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 8 5: United Kingdom - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 8 6: United Kingdom – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 9 1: France - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 9 2: France – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 9 3: France - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 9 4: France – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 9 5: France - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 9 6: France – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 10 1: Germany - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 10 2: Germany – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 10 3: Germany - Allergic Conjunctivitis Patient Treated Numbers (Million), 2013 – 2018
Figure 10 4: Germany – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 10 5: Germany - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 10 6: Germany – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 11 1: Italy - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 11 2: Italy – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 11 3: Italy - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 11 4: Italy – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 11 5: Italy - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 11 6: Italy – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 12 1: Spain - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 12 2: Spain – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 12 3: Spain - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 12 4: Spain – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 12 5: Spain - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 12 6: Spain – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 13 1: Global - Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2013 – 2018
Figure 13 2: Global – Forecast for Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2019 – 2025
Figure 13 3: Global - Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2013 – 2018
Figure 13 4: Global – Forecast for Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2019 – 2025
Figure 13 5: Global - Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2013 – 2018
Figure 13 6: Global – Forecast for Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2019 – 2025
Figure 13 7: Global - Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2013 – 2018
Figure 13 8: Global – Forecast for Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2019 – 2025
Figure 14 1: Allergic Conjunctivitis Pipe Line Drug – Zerviate Status (2018)
Figure 14 2: Allergic Conjunctivitis Pipe Line Drug – OTX-DP (Dexamethasone Insert) Status (2018)
Figure 14 3: Allergic Conjunctivitis Pipe Line Drug – ADX-102 Status (2018)
Figure 14 4: Allergic Conjunctivitis Pipe Line Drug – PRT-2761Status (2018)
Figure 14 5: Allergic Conjunctivitis Pipe Line Drug – CVXL-0074 Status (2018)
Figure 14 6: Allergic Conjunctivitis Pipe Line Drug – AK-002 Status (2018)
Figure 14 7: Allergic Conjunctivitis Pipe Line Drug – Bertilimumab Status (2018)
Figure 14 8: Allergic Conjunctivitis Pipe Line Drug – Reproxalap Status (2018)
Figure 14 9: Allergic Conjunctivitis Pipe Line Drug – ST-266 Status (2018)
Figure 14 10: Allergic Conjunctivitis Pipe Line Drug – SYL-116011 Status (2018)
Figure 17 1: Santen Pharmaceutical – Global Revenue (Million US$), 2014 - 2018
Figure 17 2: Santen Pharmaceutical – Forecast for Global Revenue (Million US$), 2019 - 2025
Figure 18 1: Alcon (Novartis) – Global Revenue (Million US$), 2014 - 2018
Figure 18 2: Alcon (Novartis) – Forecast for Global Revenue (Million US$), 2019 - 2025
Figure 19 1: Portola Pharmaceuticals – Global Revenue (Thousand US$), 2014 - 2018
Figure 19 2: Portola Pharmaceuticals – Forecast for Global Revenue (Thousand US$), 2019 - 2025
Figure 20 1: Ocular Therapeutix – Global Revenue (Thousand US$), 2014 - 2018
Figure 20 2: Ocular Therapeutix – Forecast for Global Revenue (Thousand US$), 2019 - 2025

 

List of Tables


Table 3 1: Global - Allergic Conjunctivitis Patients Population Country Share (Percent), 2013 – 2018
Table 3 2: Global – Forecast for Allergic Conjunctivitis Patients Population Country Share (Percent), 2019 – 2025